More Women Now Using Compounded Hormones without Understanding the Risks From 28% to 68% of women using hormones at menopause take compounded, so-called “bioidentical” hormones, but women don’t understand the risks of these unapproved, untested treatments, shows an analysis of ...

New Dual-Mode Clinical Decision-Support Tool Uses One-of-a-Kind Algorithm to Help Clinicians and Patients Work Together to Personalize Treatment Decisions The North American Menopause Society (NAMS) is set to launch a first-ever menopause mobile app designed for use by both clinicians ...